Figure 1
From: Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer
Impact of ATG16L1 rs78835907 on prostate cancer progression.
Kaplan-Meier estimates of (A) BCR-free survival in localized prostate cancer patients who underwent RP and (B) progression-free survival in advanced prostate cancer patients who received ADT, by ATG16L1 rs78835907 genotypes. Numbers in parentheses indicate the number of patients.
